{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T09:31:09Z","timestamp":1774258269834,"version":"3.50.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,11,17]],"date-time":"2016-11-17T00:00:00Z","timestamp":1479340800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Phi Beta Psi Sorority Charity Trust"},{"name":"University of Louisville, Office of the Executive Vice President for Research"},{"name":"CTSP award from the Commonwealth of Kentucky"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1007\/s10549-016-4049-8","type":"journal-article","created":{"date-parts":[[2016,11,17]],"date-time":"2016-11-17T12:10:00Z","timestamp":1479384600000},"page":"245-258","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Clinical outcomes linked to\u00a0expression\u00a0of gene subsets for protein hormones and their cognate receptors from LCM-procured breast\u00a0carcinoma cells"],"prefix":"10.1007","volume":"161","author":[{"given":"Michael W.","family":"Daniels","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy N.","family":"Brock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James L.","family":"Wittliff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,11,17]]},"reference":[{"issue":"4","key":"4049_CR1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1200\/JCO.1983.1.4.227","volume":"1","author":"B Fisher","year":"1983","unstructured":"Fisher B, Redmond C, Brown A, Wickerham D, Wolmark N, Allegra J, Escher G, Lippman M, Savlov E, Wittliff J (1983) Influence of tumor estrogen and progesterone receptor levels on the response to tamoxifen and chemotherapy in primary breast cancer. J Clin Oncol 1(4):227\u2013241","journal-title":"J Clin Oncol"},{"issue":"1","key":"4049_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM198107023050101","volume":"305","author":"B Fisher","year":"1981","unstructured":"Fisher B, Redmond C, Brown A, Wolmark N, Wittliff J, Fisher ER, Plotkin D, Bowman D, Sachs S, Wolter J (1981) Treatment of primary breast cancer with chemotherapy and tamoxifen. N Engl J Med 305(1):1\u20136","journal-title":"N Engl J Med"},{"key":"4049_CR3","first-page":"33","volume-title":"Tumor markers: physiology, pathobiology, technology and clinical applications","author":"M Fleisher","year":"2002","unstructured":"Fleisher M, Dnistrian AM, Sturgeon CM, Lamerz R, Wittliff JL (2002) Practice guidelines and recommendations for use of tumor markers in the clinic. In: Diamandis EP, Fritsche H, Schwartz MK, Chan DW (eds) Tumor markers: physiology, pathobiology, technology and clinical applications. AACC, Chicago, pp 33\u201363"},{"issue":"7","key":"4049_CR4","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.5858\/134.7.e48","volume":"134","author":"MEH Hammond","year":"2010","unstructured":"Hammond MEH, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, Fitzgibbons PL, Francis G, Goldstein NS, Hayes M (2010) American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version). Arch Pathol Lab Med 134(7):e48\u2013e72","journal-title":"Arch Pathol Lab Med"},{"key":"4049_CR5","first-page":"458","volume-title":"The breast: comprehensive management of benign and malignant diseases","author":"J Wittliff","year":"1998","unstructured":"Wittliff J, Pasic R, Bland K (1998) Steroid and peptide hormone receptors: methods, quality control and clinical use. In: Bland KI, Copeland EM III (eds) The breast: comprehensive management of benign and malignant diseases, 2nd edn.\u00a0WB Saunders Co, Philadelphia, pp 458\u2013498","edition":"2"},{"issue":"3 Suppl","key":"4049_CR6","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/1097-0142(19840201)53:3+<630::AID-CNCR2820531308>3.0.CO;2-3","volume":"53","author":"J Wittliff","year":"1984","unstructured":"Wittliff J (1984) Steroid-hormone receptors in breast cancer. Cancer 53(3 Suppl):630","journal-title":"Cancer"},{"issue":"18","key":"4049_CR7","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJM197911013011826","volume":"301","author":"ER DeSombre","year":"1979","unstructured":"DeSombre ER, Carbone PP, Jensen EV, McGuire WL, Wells SA Jr, Wittliff JL, Lipsett MB (1979) Special report. Steriod receptors in breast cancer. N Engl J Med 301(18):1011\u20131012","journal-title":"N Engl J Med"},{"issue":"1","key":"4049_CR8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5858\/2007-131-18-ASOCCO","volume":"131","author":"AC Wolff","year":"2007","unstructured":"Wolff AC, Hammond MEH, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, Dowsett M, Fitzgibbons PL, Hanna WM, Langer A (2007) American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. Arch Pathol Lab Med 131(1):18\u201343","journal-title":"Arch Pathol Lab Med"},{"issue":"16","key":"4049_CR9","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1056\/NEJMoa052122","volume":"353","author":"EH Romond","year":"2005","unstructured":"Romond EH, Perez EA, Bryant J, Suman VJ, Geyer CE Jr, Davidson NE, Tan-Chiu E, Martino S, Paik S, Kaufman PA (2005) Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med 353(16):1673\u20131684","journal-title":"N Engl J Med"},{"issue":"4785","key":"4049_CR10","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1126\/science.3798106","volume":"235","author":"DJ Slamon","year":"1987","unstructured":"Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2\/neu oncogene. Science 235(4785):177\u2013182","journal-title":"Science"},{"issue":"21","key":"4049_CR11","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1158\/1078-0432.CCR-14-3127","volume":"21","author":"I Gingras","year":"2015","unstructured":"Gingras I, Desmedt C, Ignatiadis M, Sotiriou C (2015) CCR 20th anniversary commentary: gene-expression signature in breast cancer\u2014where did it start and where are we now? Clin Cancer Res 21(21):4743\u20134746","journal-title":"Clin Cancer Res"},{"issue":"6797","key":"4049_CR12","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou CM, S\u00f8rlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA (2000) Molecular portraits of human breast tumours. Nature 406(6797):747\u2013752","journal-title":"Nature"},{"issue":"16","key":"4049_CR13","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1158\/1078-0432.CCR-04-2421","volume":"11","author":"R Rouzier","year":"2005","unstructured":"Rouzier R, Perou CM, Symmans WF, Ibrahim N, Cristofanilli M, Anderson K, Hess KR, Stec J, Ayers M, Wagner P (2005) Breast cancer molecular subtypes respond differently to preoperative chemotherapy. Clin Cancer Res 11(16):5678\u20135685","journal-title":"Clin Cancer Res"},{"key":"4049_CR14","first-page":"538","volume":"3","author":"J Wittliff","year":"2002","unstructured":"Wittliff J, Ma X, Stecker K, Salunga R, Tuggle J, Tran Y, Mesina K, Payette T, McQuary P, Pistone M (2002) Gene expression profiles and tumor marker signatures of human breast carcinoma cells procured by laser capture microdissection. Endocrine Soc Abs 3:538","journal-title":"Endocrine Soc Abs"},{"issue":"2","key":"4049_CR15","first-page":"101","volume":"42","author":"M Ben-David","year":"1987","unstructured":"Ben-David M, Kadar T, Wittliff J, Biran S, Schally A (1987) Characterization of prolactin receptors and their distribution among American and Israeli women with breast cancer: implications for prediction of hormonal dependency and treatment. Biomed pharmacother 42(2):101\u2013109","journal-title":"Biomed pharmacother"},{"issue":"3","key":"4049_CR16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/jcla.1860030302","volume":"3","author":"M Fekete","year":"1989","unstructured":"Fekete M, Wittliff JL, Schally AV (1989) Characteristics and distribution of receptors for [d-trp6]-luteinizing hormone-releasing hormone, somatostatin, epidermal growth factor, and sex steroids in 500 biopsy samples of human breast cancer. J Clin Lab Anal 3(3):137\u2013147","journal-title":"J Clin Lab Anal"},{"issue":"2","key":"4049_CR17","first-page":"280","volume":"55","author":"G Halmos","year":"1995","unstructured":"Halmos G, Wittliff JL, Schally AV (1995) Characterization of bombesin\/gastrin-releasing peptide receptors in human breast cancer and their relationship to steroid receptor expression. Cancer Res 55(2):280\u2013287","journal-title":"Cancer Res"},{"key":"4049_CR18","unstructured":"Genomic Health. http:\/\/www.genomichealth.com\/ . Accessed 20 March 2016"},{"key":"4049_CR19","unstructured":"Agendia. http:\/\/www.agendia.com\/ . Accessed 20 March 2016"},{"issue":"4","key":"4049_CR20","first-page":"1036","volume":"62","author":"A Chen","year":"2002","unstructured":"Chen A, Kaganovsky E, Rahimipour S, Ben-Aroya N, Okon E, Koch Y (2002) Two forms of gonadotropin-releasing hormone (GnRH) are expressed in human breast tissue and overexpressed in breast cancer a putative mechanism for the antiproliferative effect of GnRH by down-regulation of acidic ribosomal phosphoproteins P1 and P2. Cancer Res 62(4):1036\u20131044","journal-title":"Cancer Res"},{"issue":"5","key":"4049_CR21","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1210\/endo.141.5.7470","volume":"141","author":"M Falzon","year":"2000","unstructured":"Falzon M, Du P (2000) Enhanced Growth of MCF-7 breast cancer cells overexpressing parathyroid hormone-related peptide 1. Endocrinology 141(5):1882\u20131892","journal-title":"Endocrinology"},{"key":"4049_CR22","volume-title":"Hormones","author":"AW Norman","year":"2014","unstructured":"Norman AW, Henry HL (2014) Hormones. Elsevier Science, Amsterdam"},{"key":"4049_CR23","volume-title":"Protein and peptide hormones","author":"JG Pierce","year":"1982","unstructured":"Pierce JG (1982) Protein and peptide hormones. Hutchinson Ross Pub Co, Stroudsburg"},{"issue":"3","key":"4049_CR24","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s10549-015-3507-z","volume":"152","author":"SA Andres","year":"2015","unstructured":"Andres SA, Bickett KE, Alatoum MA, Kalbfleisch TS, Brock GN, Wittliff JL (2015) Interaction between smoking history and gene expression levels impacts survival of breast cancer patients. Breast Cancer Res Treat 152(3):545\u2013556","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"4049_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-13-326","volume":"13","author":"SA Andres","year":"2013","unstructured":"Andres SA, Brock GN, Wittliff JL (2013) Interrogating differences in expression of targeted gene sets to predict breast cancer outcome. BMC Cancer 13(1):1","journal-title":"BMC Cancer"},{"issue":"2","key":"4049_CR26","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s12020-011-9522-x","volume":"40","author":"SA Andres","year":"2011","unstructured":"Andres SA, Wittliff JL (2011) Relationships of ESR1 and XBP1 expression in human breast carcinoma and stromal cells isolated by laser capture microdissection compared to intact breast cancer tissue. Endocrine 40(2):212\u2013221","journal-title":"Endocrine"},{"issue":"1","key":"4049_CR27","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1515\/hmbci-2012-0025","volume":"12","author":"SA Andres","year":"2012","unstructured":"Andres SA, Wittliff JL (2012) Co-expression of genes with estrogen receptor-\u03b1 and progesterone receptor in human breast carcinoma tissue. Horm Mol Biol Clin Investig 12(1):377\u2013390","journal-title":"Horm Mol Biol Clin Investig"},{"issue":"1","key":"4049_CR28","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1515\/hmbci-2012-0025","volume":"12","author":"SA Andres","year":"2012","unstructured":"Andres SA, Wittliff JL (2012) Co-expression of genes with estrogen receptor-alpha and progesterone receptor in human breast carcinoma tissue. Horm Mol Biol Clin Investig 12(1):377\u2013390","journal-title":"Horm Mol Biol Clin Investig"},{"key":"4049_CR29","unstructured":"Ma X, Wang W, Salunga R, Tuggle T, Stecker K, Baer T, Erlander M, Wittliff J (2003) Gene expression signatures associated with clinical outcome in breast cancer via laser capture microdissection. Breast Cancer Res Treat 82:S15"},{"issue":"4","key":"4049_CR30","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s12672-013-0141-2","volume":"4","author":"SA Andres","year":"2013","unstructured":"Andres SA, Wittliff JL, Cheng A (2013) Protein tyrosine phosphatase 4A2 expression predicts overall and disease-free survival of human breast cancer and is associated with estrogen and progestin receptor status. Horm Cancer 4(4):208\u2013221","journal-title":"Horm Cancer"},{"issue":"5","key":"4049_CR31","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s12672-011-0080-8","volume":"2","author":"DA Kerr II","year":"2011","unstructured":"Kerr DA II, Wittliff JL (2011) A five-gene model predicts clinical outcome in ER+\/PR+, early-stage breast cancers treated with adjuvant tamoxifen. Horm Cancer 2(5):261\u2013271","journal-title":"Horm Cancer"},{"issue":"2","key":"4049_CR32","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10549-006-9242-8","volume":"100","author":"LM McShane","year":"2006","unstructured":"McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM (2006) Statistics subcommittee of NCIEWGoCD: reporting recommendations for tumor marker prognostic studies (REMARK). Breast Cancer Res Treat 100(2):229\u2013235","journal-title":"Breast Cancer Res Treat"},{"issue":"16","key":"4049_CR33","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/j.clinbiochem.2013.07.005","volume":"46","author":"TL Kruer","year":"2013","unstructured":"Kruer TL, Cummins TD, Powell DW, Wittliff JL (2013) Characterization of estrogen response element binding proteins as biomarkers of breast cancer behavior. Clin Biochem 46(16):1739\u20131746","journal-title":"Clin Biochem"},{"issue":"7","key":"4049_CR34","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1080\/00365520902898127","volume":"44","author":"HB El-Serag","year":"2009","unstructured":"El-Serag HB, Nurgalieva ZZ, Mistretta T-A, Finegold MJ, Souza R, Hilsenbeck S, Shaw C, Darlington G (2009) Gene expression in Barrett\u2019s Esophagus: laser capture vs. whole tissue. Scand J Gastroenterol 44(7):787","journal-title":"Scand J Gastroenterol"},{"key":"4049_CR35","volume-title":"Basic and clinical endocrinology","author":"FS Greenspan","year":"1997","unstructured":"Greenspan FS, Gardner DG, Shoback D (1997) Basic and clinical endocrinology. Appleton & Lange, Stamford"},{"issue":"3","key":"4049_CR36","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0165-6147(00)88988-9","volume":"16","author":"D Hoyer","year":"1995","unstructured":"Hoyer D, Bell GI, Berelowitz M, Epelbaum J, Feniuk W, Humphrey PP, O\u2019Carroll AM, Patel YC, Schonbrunn A, Taylor JE et al (1995) Classification and nomenclature of somatostatin receptors. Trends Pharmacol Sci 16(3):86\u201388","journal-title":"Trends Pharmacol Sci"},{"issue":"2\u20133","key":"4049_CR37","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0165-0173(00)00031-X","volume":"33","author":"AD Spier","year":"2000","unstructured":"Spier AD, de Lecea L (2000) Cortistatin: a member of the somatostatin neuropeptide family with distinct physiological functions. Brain Res Brain Res Rev 33(2\u20133):228\u2013241","journal-title":"Brain Res Brain Res Rev"},{"key":"4049_CR38","unstructured":"Therneau T (2013) A package for survival analysis in S. R package version 2.37-4. http:\/\/www.CRANR-projectorg\/package=survivalBox980032:23298-20032"},{"issue":"11","key":"4049_CR39","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.jclinepi.2004.04.003","volume":"57","author":"PC Austin","year":"2004","unstructured":"Austin PC, Tu JV (2004) Automated variable selection methods for logistic regression produced unstable models for predicting acute myocardial infarction mortality. J Clin Epidemiol 57(11):1138\u20131146","journal-title":"J Clin Epidemiol"},{"key":"4049_CR40","unstructured":"Goeman J, Meijer R, Chaturvedi N (2014) L1 and L2 penalized regression models. R package Version 0.9-45"},{"issue":"1","key":"4049_CR41","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/bimj.200900028","volume":"52","author":"JJ Goeman","year":"2010","unstructured":"Goeman JJ (2010) L1 penalized estimation in the Cox proportional hazards model. Biometrical J 52(1):70\u201384","journal-title":"Biometrical J"},{"key":"4049_CR42","unstructured":"Harrell FE Jr (2014) Hmisc: harrell miscellaneous;\u00a0Regression modeling strategies.\u00a0 http:\/\/CRAN.R-project.org\/package=rms"},{"issue":"9","key":"4049_CR43","doi-asserted-by":"crossref","first-page":"e74250","DOI":"10.1371\/journal.pone.0074250","volume":"8","author":"R Aguirre-Gamboa","year":"2013","unstructured":"Aguirre-Gamboa R, Gomez-Rueda H, Mart\u00ednez-Ledesma E, Mart\u00ednez-Torteya A, Chacolla-Huaringa R, Rodriguez-Barrientos A, Tamez-Pena JG, Trevino V (2013) SurvExpress: an online biomarker validation tool and database for cancer gene expression data using survival analysis. PLoS ONE 8(9):e74250","journal-title":"PLoS ONE"},{"issue":"2","key":"4049_CR44","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cmet.2006.01.006","volume":"3","author":"YS Lee","year":"2006","unstructured":"Lee YS, Challis BG, Thompson DA, Yeo GS, Keogh JM, Madonna ME, Wraight V, Sims M, Vatin V, Meyre D et al (2006) A POMC variant implicates beta-melanocyte-stimulating hormone in the control of human energy balance. Cell Metab 3(2):135\u2013140","journal-title":"Cell Metab"},{"issue":"4","key":"4049_CR45","doi-asserted-by":"crossref","first-page":"T77","DOI":"10.1530\/JME-15-0323","volume":"56","author":"NX Cawley","year":"2016","unstructured":"Cawley NX, Li Z, Loh YP (2016) 60 Years of POMC: biosynthesis, trafficking, and secretion of pro-opiomelanocortin-derived peptides. J Mol Endocrinol 56(4):T77\u2013T97","journal-title":"J Mol Endocrinol"},{"key":"4049_CR46","doi-asserted-by":"crossref","first-page":"e006","DOI":"10.1621\/nrs.12006","volume":"12","author":"NJ McKenna","year":"2014","unstructured":"McKenna NJ, Evans RM, O\u2019Malley BW (2014) Nuclear receptor signaling: a home for nuclear receptor and coregulator signaling research. Nucl recept signal 12:e006","journal-title":"Nucl recept signal"},{"issue":"3 Suppl","key":"4049_CR47","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/1097-0142(19840201)53:3+<630::AID-CNCR2820531308>3.0.CO;2-3","volume":"53","author":"JL Wittliff","year":"1984","unstructured":"Wittliff JL (1984) Steroid-hormone receptors in breast cancer. Cancer 53(3 Suppl):630\u2013643","journal-title":"Cancer"},{"issue":"3\u20134","key":"4049_CR48","first-page":"160","volume":"5","author":"JL Wittliff","year":"1987","unstructured":"Wittliff JL (1987) Molecular basis of endocrine-responsive cancers. Clin Physiol Biochem 5(3\u20134):160\u2013178","journal-title":"Clin Physiol Biochem"},{"issue":"1\u20133","key":"4049_CR49","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0960-0760(92)90203-U","volume":"43","author":"M Blankenstein","year":"1992","unstructured":"Blankenstein M, Maitimu-Smeele I, Donker G, Daroszewski J, Milewicz A, Thijssen J (1992) Tissue androgens and the endocrine autonomy of breast cancer. J Steroid Biochem Mol Biol 43(1\u20133):167\u2013171","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1","key":"4049_CR50","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100(1):57\u201370","journal-title":"Cell"},{"issue":"10","key":"4049_CR51","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1113205","volume":"366","author":"M Gerlinger","year":"2012","unstructured":"Gerlinger M, Rowan AJ, Horswell S, Larkin J, Endesfelder D, Gronroos E, Martinez P, Matthews N, Stewart A, Tarpey P (2012) Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 366(10):883\u2013892","journal-title":"N Engl J Med"},{"key":"4049_CR52","first-page":"463","volume-title":"Techniques in confocal microscopy","author":"JL Wittliff","year":"2010","unstructured":"Wittliff JL (2010) Laser capture microdissection and its use in genomics and proteomics, in reliable lab solutions. In: Conn PM (ed) Techniques in confocal microscopy. Elsevier, Amsterdam, pp 463\u2013477"},{"key":"4049_CR53","first-page":"377","volume-title":"Hormonal carcinogenesis V","author":"A Kerr II","year":"2008","unstructured":"Kerr A II, Eliason JF, Wittliff JL (2008) Steroid receptor and growth factor receptor expression in human nonsmall cell lung cancers using cells procured by laser-capture microdissection. In: Li JJ et al (eds) Hormonal carcinogenesis V. Springer, Berlin, pp 377\u2013384"},{"issue":"1","key":"4049_CR54","first-page":"66","volume":"23","author":"JL Wittliff","year":"2000","unstructured":"Wittliff JL, Kunitake ST, Chu SS, Travis JC (2000) Applications of laser capture microdissection in genomics and proteomics. J Clin Ligand Assay 23(1):66\u201373","journal-title":"J Clin Ligand Assay"},{"key":"4049_CR55","first-page":"41","volume-title":"Cancer medicine","author":"P Fedi","year":"1997","unstructured":"Fedi P, Tronick SR, Aaronson SA (1997) Growth factors. In: Holland JF, Bast RC, Morton DL et al (eds) Cancer medicine. Williams & Wilkins, Baltimore, pp 41\u201364"},{"key":"4049_CR56","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/978-3-319-22542-5_5","volume-title":"Medullary thyroid carcinoma","author":"YJ Bae","year":"2015","unstructured":"Bae YJ, Schaab M, Kratzsch J (2015) Calcitonin as biomarker for the medullary thyroid carcinoma. In: Raue F (ed) Medullary thyroid carcinoma. Springer, Berlin, pp 117\u2013137"},{"issue":"27","key":"4049_CR57","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1056\/NEJMoa041588","volume":"351","author":"S Paik","year":"2004","unstructured":"Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, Baehner FL, Walker MG, Watson D, Park T (2004) A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351(27):2817\u20132826","journal-title":"N Engl J Med"},{"issue":"10","key":"4049_CR58","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1245\/s10434-012-2561-6","volume":"19","author":"B Nguyen","year":"2012","unstructured":"Nguyen B, Cusumano PG, Deck K, Kerlin D, Garcia AA, Barone JL, Rivera E, Yao K, de Snoo FA, van den Akker J (2012) Comparison of molecular subtyping with BluePrint, MammaPrint, and TargetPrint to local clinical subtyping in breast cancer patients. Ann Surg Oncol 19(10):3257\u20133263","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"4049_CR59","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1075-122X.2004.21467.x","volume":"10","author":"MF Pelte","year":"2004","unstructured":"Pelte MF, Schwaller J, Cerrato C, Meier CA (2004) Pro-opiomelanocortin expression in a metastatic breast carcinoma with ectopic ACTH secretion. Breast J 10(4):350\u2013354","journal-title":"Breast J"},{"issue":"5","key":"4049_CR60","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ghir.2006.09.006","volume":"16","author":"JK Perry","year":"2006","unstructured":"Perry JK, Emerald BS, Mertani HC, Lobie PE (2006) The oncogenic potential of growth hormone. Growth Hormon IGF Res 16(5):277\u2013289","journal-title":"Growth Hormon IGF Res"},{"issue":"2","key":"4049_CR61","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1023\/B:BREA.0000010703.59483.c0","volume":"83","author":"X Wang","year":"2004","unstructured":"Wang X, Nakamura M, Mori I, Takeda K, Nakamura Y, Utsunomiya H, Yoshimura G, Sakurai T, Kakudo K (2004) Calcitonin receptor gene and breast cancer: quantitative analysis with laser capture microdissection. Breast Cancer Res Treat 83(2):109\u2013117","journal-title":"Breast Cancer Res Treat"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-016-4049-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-016-4049-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-016-4049-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T17:24:58Z","timestamp":1718904298000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-016-4049-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,17]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["4049"],"URL":"https:\/\/doi.org\/10.1007\/s10549-016-4049-8","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,17]]}}}